ICH Stability program to support semipermeable conditions. Regulatory team supports project throughout regulatory lifecycle.
Dedicated multidisciplinary team to support all aspects of development from method development, method validation, sterility & bioburden along with our robust microbiology lab.
Development engineering teams lead all aspects of product development/transfers from the clinical study stage and manage projects throughout the development lifecycle, process validation & commercial launch.
TRC registers with FDA as a 503B Outsourcing and Repackaging Facility
Plant expansion of over 150,000 sq ft for packaging and distribution
TRC acquired by international investors led by private equity firms based in the U.S. and Hong Kong
TRC obtains fourth ANDA and has an annual capacity of 1.7 Billion units with 10 BFS machines, 4 fully automatic packaging lines and 1 semi-automatic packing line
EU compliant expansion Quality & Development Lab expansion
TRC obtains third ANDA
Olympus Partners acquires Holopack International and forms The Ritedose Corporation